Literature DB >> 27346989

Obesity-related metabolite profiles of black women spanning the epidemiologic transition.

Lara R Dugas1, Elin Chorell2, Jacob Plange-Rhule3, Estelle V Lambert4, Guichan Cao1, Richard S Cooper1, Brian T Layden5, Denise Scholten6, Tommy Olsson2, Amy Luke1, Julia H Goedecke7.   

Abstract

In developed countries, specific metabolites have been associated with obesity and metabolic diseases, e.g. type 2 diabetes. It is unknown whether a similar profile persists across populations of African-origin, at increased risk for obesity and related diseases. In a cross-sectional study of normal-weight and obese black women (33.3 ± 6.3 years) from the US (N = 69, 65 % obese), South Africa (SA, N = 97, 49 % obese) and Ghana (N = 82, 33 % obese) serum metabolite profiles were characterized via gas chromatography-time of flight/mass spectrometry. In US and SA women, BMI correlated with branched-chain and aromatic amino acids, as well as dopamine and aminoadipic acid. The relationship between BMI and lipid metabolites differed by site; BMI correlated positively with palmitoleic acid (16:1) in the US; negatively with stearic acid (18:0) in SA, and positively with arachidonic acid (20:4) in Ghana. BMI was also positively associated with sugar-related metabolites in the US; i.e. uric acid, and mannitol, and with glucosamine, glucoronic acid and mannitol in SA. While we identified a common amino acid metabolite profile associated with obesity in black women from the US and SA, we also found site-specific obesity-related metabolites suggesting that the local environment is a key moderator of obesity.

Entities:  

Keywords:  African-origin; Amino acid profile; Obesity

Year:  2016        PMID: 27346989      PMCID: PMC4915364          DOI: 10.1007/s11306-016-0960-6

Source DB:  PubMed          Journal:  Metabolomics        ISSN: 1573-3882            Impact factor:   4.290


  41 in total

1.  Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement.

Authors:  Sherita Hill Golden; Arleen Brown; Jane A Cauley; Marshall H Chin; Tiffany L Gary-Webb; Catherine Kim; Julie Ann Sosa; Anne E Sumner; Blair Anton
Journal:  J Clin Endocrinol Metab       Date:  2012-06-22       Impact factor: 5.958

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 3.  Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin.

Authors:  Peter J Havel
Journal:  Curr Opin Lipidol       Date:  2002-02       Impact factor: 4.776

Review 4.  Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?

Authors:  Zohreh Soltani; Kashaf Rasheed; Daniel R Kapusta; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

5.  Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS).

Authors:  Tae Nyun Kim; Man Sik Park; Sae Jeong Yang; Hye Jin Yoo; Hyun Joo Kang; Wook Song; Ji A Seo; Sin Gon Kim; Nan Hee Kim; Sei Hyun Baik; Dong Seop Choi; Kyung Mook Choi
Journal:  Diabetes Care       Date:  2010-04-22       Impact factor: 19.112

6.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance.

Authors:  Christopher B Newgard; Jie An; James R Bain; Michael J Muehlbauer; Robert D Stevens; Lillian F Lien; Andrea M Haqq; Svati H Shah; Michelle Arlotto; Cris A Slentz; James Rochon; Dianne Gallup; Olga Ilkayeva; Brett R Wenner; William S Yancy; Howard Eisenson; Gerald Musante; Richard S Surwit; David S Millington; Mark D Butler; Laura P Svetkey
Journal:  Cell Metab       Date:  2009-04       Impact factor: 27.287

Review 7.  Dietary fat, fatty acid composition in plasma and the metabolic syndrome.

Authors:  Bengt Vessby
Journal:  Curr Opin Lipidol       Date:  2003-02       Impact factor: 4.776

8.  An interaction effect between glucokinase gene variation and carbohydrate intakes modulates the plasma triglyceride response to a fish oil supplementation.

Authors:  Annie Bouchard-Mercier; Iwona Rudkowska; Simone Lemieux; Patrick Couture; Marie-Claude Vohl
Journal:  Genes Nutr       Date:  2014-03-19       Impact factor: 5.523

9.  Validated and predictive processing of gas chromatography-mass spectrometry based metabolomics data for large scale screening studies, diagnostics and metabolite pattern verification.

Authors:  Elin Thysell; Elin Chorell; Michael B Svensson; Pär Jonsson; Henrik Antti
Journal:  Metabolites       Date:  2012-10-31

10.  Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples.

Authors:  Pär Jonsson; Anna Wuolikainen; Elin Thysell; Elin Chorell; Pär Stattin; Pernilla Wikström; Henrik Antti
Journal:  Metabolomics       Date:  2015-06-02       Impact factor: 4.290

View more
  2 in total

Review 1.  Metabolomics prospect of obesity and metabolic syndrome; a systematic review.

Authors:  Moloud Payab; Akram Tayanloo-Beik; Khadijeh Falahzadeh; Maryamossadat Mousavi; Saeede Salehi; Shirin Djalalinia; Mahbube Ebrahimpur; Nafiseh Rezaei; Mostafa Rezaei-Tavirani; Bagher Larijani; Babak Arjmand; Kambiz Gilany
Journal:  J Diabetes Metab Disord       Date:  2021-11-26

2.  Decreased microbial co-occurrence network stability and SCFA receptor level correlates with obesity in African-origin women.

Authors:  Lara R Dugas; Beatriz Peñalver Bernabé; Medha Priyadarshini; Na Fei; Seo Jin Park; Laquita Brown; Jacob Plange-Rhule; David Nelson; Evelyn C Toh; Xiang Gao; Qunfeng Dong; Jun Sun; Stephanie Kliethermes; Neil Gottel; Amy Luke; Jack A Gilbert; Brian T Layden
Journal:  Sci Rep       Date:  2018-11-20       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.